Literature DB >> 2508716

Faecal mycobacteria and their relationship to HIV-related enteritis in Lusaka, Zambia.

C P Conlon1, H M Banda, N P Luo, M K Namaambo, C U Perera, J Sikweze.   

Abstract

The prevalence of infection with mycobacteria, both typical and atypical, is increasing along with prevalence of infection with HIV. Patients with pulmonary tuberculosis (PTB) and patients with chronic diarrhoea are forming a growing proportion of the patient population in hospitals in central Africa. To investigate the possibility that mycobacteria may be responsible for some of the HIV-related enteropathy seen in Lusaka, we studied 89 patients in four different diagnostic groups, clinically, by Mantoux test and by microscopy and culture of stool specimens for mycobacteria. In the HIV-positive group with chronic diarrhoea (n = 31), two patients were found to have mycobacteria on faecal smear and three were culture positive while of the 15 HIV-negative controls, three were smear positive and three were culture positive. Of the 15 patients with proven PTB, three had positive faecal smears but none were culture positive. In the fourth group of 24 patients with suspected PTB, seven were smear positive and five, culture positive. Only in this last group was there some correlation between smear results and culture results. Although this last finding is difficult to explain, it appears that there is no correlation between the symptom of chronic diarrhoea and the presence of mycobacteria in the stool. We conclude that mycobacteria do not play a significant role in the pathogenesis of HIV-related enteropathy in Lusaka.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Control Groups; Data Collection; Developing Countries; Diarrhea--etiology; Diseases; Eastern Africa; English Speaking Africa; Examinations And Diagnoses; Hiv Infections; Laboratory Examinations And Diagnoses; Research Methodology; Treatment; Viral Diseases; Zambia

Mesh:

Substances:

Year:  1989        PMID: 2508716     DOI: 10.1097/00002030-198908000-00009

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  6 in total

1.  Evaluation of molecular tools for detection and drug susceptibility testing of Mycobacterium tuberculosis in stool specimens from patients with pulmonary tuberculosis.

Authors:  Julianna Cordova; Ron Shiloh; Robert H Gilman; Patricia Sheen; Laura Martin; Fanny Arenas; Luz Caviedes; Vivian Kawai; Giselle Soto; Diana L Williams; Mirko Zimic; A Roderick Escombe; Carlton A Evans
Journal:  J Clin Microbiol       Date:  2010-03-03       Impact factor: 5.948

2.  Chronic diarrhoea among HIV-infected adult patients in Nairobi, Kenya.

Authors:  C Mwachari; B I Batchelor; J Paul; P G Waiyaki; C F Gilks
Journal:  J Infect       Date:  1998-07       Impact factor: 6.072

3.  The utility of stool cultures for diagnosing tuberculosis in people living with the human immunodeficiency virus.

Authors:  G E Oramasionwu; C M Heilig; N Udomsantisuk; M E Kimerling; B Eng; H D Nguyen; S Thai; C Keo; K D McCarthy; J K Varma; K P Cain
Journal:  Int J Tuberc Lung Dis       Date:  2013-08       Impact factor: 2.373

4.  Causes of chronic diarrhea in patients with AIDS in Thailand: a prospective clinical and microbiological study.

Authors:  S Manatsathit; S Tansupasawasdikul; D Wanachiwanawin; S Setawarin; P Suwanagool; S Prakasvejakit; S Leelakusolwong; B Eampokalap; U Kachintorn
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

5.  Comparison of four decontamination methods for recovery of Mycobacterium avium complex from stools.

Authors:  D M Yajko; P S Nassos; C A Sanders; P C Gonzalez; A L Reingold; C R Horsburgh; P C Hopewell; D P Chin; W K Hadley
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

6.  Clinical and ultrasonographic features of abdominal tuberculosis in HIV positive adults in Zambia.

Authors:  Edford Sinkala; Sylvia Gray; Isaac Zulu; Victor Mudenda; Lameck Zimba; Sten H Vermund; Francis Drobniewski; Paul Kelly
Journal:  BMC Infect Dis       Date:  2009-04-17       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.